Financial comparisons DaShenLin Pharmaceutical Group Co., Ltd.
Equities
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.55 CNY | -0.41% |
|
+2.62% | +10.95% |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 3.63B | 3.45% | 5.66% | 13.17% | 3.5% | -0.4x | |
| 7.97B | 7.16% | 2.54% | 7.96% | 6.14% | -13.27x | |
| 4.22B | 4.68% | 4.83% | 9.28% | 7.01% | -5.08x | |
| 7.09B | 5.15% | 7.73% | 10.6% | 12% | -1.05x | |
| 2.71B | 6.77% | 9.78% | 49.2% | 14.9% | -0.5x | |
| 3.3B | 6.35% | 9.16% | 14.67% | 5.87% | -0.92x | |
| 2.52B | 8.69% | 9.24% | 32.51% | 14.22% | 0.36x | |
| 5.77B | 4.08% | 6.46% | 20.43% | - | -0.49x | |
| 1.23B | -8.96% | -5.12% | - | - | - | |
| 2.11B | 3.01% | 5.37% | 24.33% | 6.42% | 1.74x | |
| 2.45B | -1.92% | -1.47% | -9.04% | -4.49% | 4.52x | |
| 2.47B | 0.63% | 1.54% | 1.5% | 0.68% | -1.05x | |
| 718M | 2.45% | 3.87% | 9.06% | - | -0.92x | |
| 1.72B | 5.74% | 7.97% | 26.73% | 7.6% | 2.29x | |
| 1.38B | 3.52% | 4.81% | 14.2% | 8.21% | 1.77x | |
| 2.19B | 0.76% | 3.23% | 5.66% | 1.69% | 2.02x | |
| 593M | 3.27% | 4.42% | 41.61% | - | 0.54x | |
| Average | 3.06B | 3.23% | 4.71% | 16.99% | 6.44% | -0.65x | |
| Weighted average by Cap. | 5.15B | 5.17% | 4.75% | 14.06% | 7.43% | -5.48x |
- Stock Market
- Equities
- 603233 Stock
- Sector DaShenLin Pharmaceutical Group Co., Ltd.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition